Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367910 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbiota Transplantation (FMT) for MDRO UTI
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT03367910 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1 participants.
The verdict
NCT03367910, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and impact of fecal microbiota transplantation (FMT) on the fecal and urine microbiome, urine metabolome, risk of recurrent urinary tract infection (UTI), and persistent multidrug resistant organism (MDRO) colonization of patients with a history of recurrent MDRO UTIs. This is an open label phase 1-2 study.
Interventions
- DRUG Fecal microbiota transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367910
The ClinicalTrials.gov registry entry for NCT03367910 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal microbiota transplant is the first listed.
NCT03367910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367910 about?
NCT03367910 is a clinical study titled "Fecal Microbiota Transplantation (FMT) for MDRO UTI". The purpose of this study is to determine the safety and impact of fecal microbiota transplantation (FMT) on the fecal and urine microbiome, urine metabolome, risk of recurrent urinary tract infection (UTI), and persistent multidrug resistant organism (MDRO) colonization of patients with a history o...
What is the current status of trial NCT03367910?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2018-02-08. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03367910?
The interventions under investigation include: Fecal microbiota transplant (DRUG).
Who is sponsoring clinical trial NCT03367910?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.